Nanopore and Big Data: Difference between revisions

From Federal Burro of Information
Jump to navigationJump to search
 
(6 intermediate revisions by the same user not shown)
Line 4: Line 4:


* Oxford Nanopore Technologies https://nanoporetech.com/
* Oxford Nanopore Technologies https://nanoporetech.com/
* Illumina  , was in an agreement with nanopore and that's been broken off. they are going to do their own thing (  
* Illumina  , was in an agreement with nanopore and that's been broken off. they are going to do their own thing ( http://www.illumina.com/ )
* http://www.454.com/
 
[[SWOT]]
[[SWOT]]


Line 14: Line 16:
* Training?
* Training?
* Maintanace / Manged place
* Maintanace / Manged place
* CLoud offering
* Cloud offering


'''Weakness'''
'''Weakness'''
Line 22: Line 24:
*  
*  


'''Opertunity''
'''Oportunity'''
 
*


* canada does lots of genetic research.
* canada does lots of genetic research.


'''Threat'''
* quagmired.
* long lead times
* poor margin
* incumbent owns vertical
*


Home work:
Home work:
Line 38: Line 49:


== references  ==
== references  ==
blogs:


[https://biomickwatson.wordpress.com/2014/09/07/thoughts-on-oxford-nanopores-minion-mobile-dna-sequencer/ Thoughts on Oxford Nanopore’s MinION mobile DNA sequencer ]
[https://biomickwatson.wordpress.com/2014/09/07/thoughts-on-oxford-nanopores-minion-mobile-dna-sequencer/ Thoughts on Oxford Nanopore’s MinION mobile DNA sequencer ]


[https://biomickwatson.wordpress.com/2013/11/12/nanopore-wars/ Nanopore wars]
[https://biomickwatson.wordpress.com/2013/11/12/nanopore-wars/ Nanopore wars]
news release:
http://newmediacanada.ca/article.php?id_article=10789
http://isis-innovation.com/success-stories/gene-sequencing-oxford-nanopore-technologies/
http://www.theguardian.com/science/2012/feb/17/dna-machine-human-sequencing ( 2012 )
research clues:
http://www.highbeam.com/doc/1G1-243635742.html

Latest revision as of 14:36, 23 April 2015

Thesis: We should get into the nanopore market.

who are the players ( Nanopore manufactures )

SWOT

Stregnth

  • Big data mating
  • Margins?
  • Sales cycle?
  • Training?
  • Maintanace / Manged place
  • Cloud offering

Weakness

  • long lead times , long sales cycles.
  • specialized knowledge

Oportunity

  • canada does lots of genetic research.

Threat

  • quagmired.
  • long lead times
  • poor margin
  • incumbent owns vertical

Home work:

  • who ar the clients?
  • how long are lead times?
  • what do margins look like?
  • is there a managed play?
  • studio cloud like dedicated DC?


references

blogs:

Thoughts on Oxford Nanopore’s MinION mobile DNA sequencer

Nanopore wars

news release:

http://newmediacanada.ca/article.php?id_article=10789

http://isis-innovation.com/success-stories/gene-sequencing-oxford-nanopore-technologies/

http://www.theguardian.com/science/2012/feb/17/dna-machine-human-sequencing ( 2012 )

research clues:

http://www.highbeam.com/doc/1G1-243635742.html